Pharmaceuticals: Japan Industry Guide is an essential resource for top-level data and analysis covering the Japan Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
* The Japanese biotechnology market grew by 8.2% in 2007 to reach a value of $17,447 million.
* The Japanese generics market generated total revenues of $5.3 billion in 2007, representing a compound annual growth rate (CAGR) of 6.3% for the period spanning 2003-2007.
* The Japanese OTC pharmaceuticals market generated total revenues of $14.5 billion in 2008, representing a compound annual growth rate (CAGR) of 1.6% for the period spanning 2004-2008.
* The Japanese pharmaceutical market generated total revenues of $65.3 billion in 2008, representing a compound annual growth rate (CAGR) of 2.4% for the period spanning 2004-2008.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
CHAPTER 1 BIOTECHNOLOGY IN JAPAN 10
1.1 Market Overview 10
1.2 Market Value 12
1.3 Market Segmentation I 13
1.4 Market Segmentation II 14
1.5 Five Forces Analysis 15
1.6 Market Forecasts 21
CHAPTER 2 GENERICS IN JAPAN 22
2.1 Market Overview 22
2.2 Market Value 24
2.3 Market Segmentation I 25
2.4 Market Segmentation II 26
2.5 Five Forces Analysis 27
2.6 Market Forecasts 34
CHAPTER 3 OTC PHARMACEUTICALS IN JAPAN 35
3.1 Market Overview 35
3.2 Market Value 37
3.3 Market Segmentation I 38
3.4 Market Segmentation II 39
3.5 Market Share 40
3.6 Five Forces Analysis 41
3.7 Distribution 47
3.8 Market Forecasts 48
CHAPTER 4 PHARMACEUTICALS IN JAPAN 49
4.1 Market Overview 49
4.2 Market Value 51
4.3 Market Segmentation I 52
4.4 Market Segmentation II 53
4.5 Market Share 54
4.6 Five Forces Analysis 55
4.7 Market Forecasts 62
CHAPTER 5 DEMOGRAPHICS 63
CHAPTER 6 APPENDIX 64
6.1 Data Research Methodology 64
LIST OF TABLES
Table 1: Japan Biotechnology Market Value: $ million, 2003-2007 12
Table 2: Japan Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Table 3: Japan Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Table 4: Japan Biotechnology Market Value Forecast: $ million, 2007-2012 21
Table 5: Japan Generics Market Value: $ billion, 2003-2007 24
Table 6: Japan Generics Market Segmentation I: % Share, by Value, 2007 25
Table 7: Japan Generics Market Segmentation II: % Share, by Value, 2007 26
Table 8: Japan Generics Market Value Forecast: $ billion, 2007-2012 34
Table 9: Japan OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 37
Table 10: Japan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Table 11: Japan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Table 12: Japan OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Table 13: Japan OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 47
Table 14: Japan OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 48
Table 15: Japan Pharmaceuticals Market Value: $ million, 2003-2007 51
Table 16: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 52
Table 17: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 53
Table 18: Japan Pharmaceuticals Market Share: % Share, by Value, 2007 54
Table 19: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012 62
Table 20: Japan Size of Population (million) , 2003-2007 63
Table 21: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007 63
Table 22: Japan Exchange Rate, 2003 63
LIST OF FIGURES
Figure 1: Japan Biotechnology Market Value: $ million, 2003-2007 12
Figure 2: Japan Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Figure 3: Japan Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Figure 4: Forces Driving Competition in the Biotechnology Market in Japan, 2007 15
Figure 5: Drivers of Buyer Power in the Biotechnology Market in Japan, 2007 16
Figure 6: Drivers of Supplier Power in the Biotechnology Market in Japan, 2007 17
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Japan, 2007 18
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Japan, 2007 19
Figure 9: Drivers of Degree of Rivalry in the MARKET NAME in COUNTRY, 2007 20
Figure 10: Japan Biotechnology Market Value Forecast: $ million, 2007-2012 21
Figure 11: Japan Generics Market Value: $ billion, 2003-2007 24
Figure 12: Japan Generics Market Segmentation I: % Share, by Value, 2007 25
Figure 13: Japan Generics Market Segmentation II: % Share, by Value, 2007 26
Figure 14: Forces Driving Competition in the Generics Market in Japan, 2007 27
Figure 15: Drivers of Buyer Power in the Generics Market in Japan, 2007 29
Figure 16: Drivers of Supplier Power in the Generics Market in Japan, 2007 30
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in Japan, 2007 31
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in Japan, 2007 32
Figure 19: Drivers of Degree of Rivalry in the Generics Market in Japan, 2007 33
Figure 20: Japan Generics Market Value Forecast: $ billion, 2007-2012 34
Figure 21: Japan OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 37
Figure 22: Japan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Figure 23: Japan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Figure 24: Japan OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in Japan 41
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Japan 42
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Japan 43
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Japan 44
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Japan 45
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Japan 46
Figure 31: Japan OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 47
Figure 32: Japan OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 48
Figure 33: Japan Pharmaceuticals Market Value: $ million, 2003-2007 51
Figure 34: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 52
Figure 35: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 53
Figure 36: Japan Pharmaceuticals Market Share: % Share, by Value, 2007 54
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in Japan, 2007 55
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in Japan, 2007 56
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in Japan, 2007 57
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Japan, 2007 59
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Japan, 2007 60
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Japan, 2007 61
Figure 43: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012 62
Other selected research from the 'Japan' category:
The Japanese Pharmaceutical Companies Outlook: An analysis of key players and growth strategies
Pharmaceuticals - Global Group of Eight (G8) Industry Guide
Other selected research from the 'Markets' category:
Pharmaceutical Market Trends, 2008 - 2012: Key market forecasts and growth opportunities (3rd Edition)
OTC Pharmaceuticals in Europe